Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship

Рекомендации Общества инфекционных болезней Америки и Общества эпидемиологии здравоохранения Америки по разработке институциональной программы повышения эффективности управления применением противомикробных препаратов
John E. McGowan, John P. Burke, Patrick J. Brennan, Dale N. Gerding, David L. Paterson, Timothy H. Dellit, Robert C. Owens, Robert A. Weinstein, W. Charles Huskins, Neil O. Fishman, Christopher Carpenter, Marianne Billeter, Thomas M. Hooton
2006-12-19

Clostridium difficileantimicrobial resistanceantimicrobial stewardshipantimicrobial therapyinstitutional programs
This document presents guidelines for developing institutional programs to enhance antimicrobial stewardship, an activity that includes appropriate selection, dosing, route, and duration of antimicrobial therapy.The multifaceted nature of antimicrobial stewardship has led to collaborative review and support of these recommendations by the following organizations: American Academy of Pediatrics, American Society of Health-System Pharmacists, Infectious Diseases Society for Obstetrics and Gynecology, Pediatric Infectious Diseases Society, Society for Hospital Medicine, and Society of Infectious Diseases Pharmacists.The primary goal of antimicrobial stewardship is to optimize clinical outcomes while minimizing unintended consequences of antimicrobial use, including toxicity, the selection of pathogenic organisms (such as Clostridium difficile), and the emergence of resistance.Thus, the appropriate use of antimicrobials is an essential part of patient safety
1
Appropriate antimicrobial use is identified as an essential component of patient safety.
2
The guidelines provide a framework for developing institutional antimicrobial stewardship programs focused on appropriate antimicrobial selection, dosing, route, and duration.
3
The primary goal of antimicrobial stewardship is to optimize clinical outcomes while minimizing antimicrobial toxicity, selection of pathogens such as Clostridium difficile, and antimicrobial resistance.
4
The recommendations received collaborative review and support from multiple professional organizations, reflecting the multidisciplinary nature of antimicrobial stewardship.

Institutional antimicrobial stewardship program

development of programs that optimize antimicrobial selection, dosing, route, and duration while improving clinical outcomes and minimizing toxicity, Clostridium difficile, and antimicrobial resistance

Publication Details
Publication Date
2006-12-19
Journal
Publisher
ISSN
Access Type
Author Information
Authors
John E. McGowan
John P. Burke
Patrick J. Brennan
Dale N. Gerding
David L. Paterson
Timothy H. Dellit
Robert C. Owens
Robert A. Weinstein
W. Charles Huskins
Neil O. Fishman
Christopher Carpenter
Marianne Billeter
Thomas M. Hooton
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%